DocMorris Apotek has recorded turnover of SEK205.4m (£19.9m) and a loss of SEK121.5m (£11.7m) during its first 10 months of trading to end of December 2010.

The company said that its strategy was to invest only in new locations and to establish a brand, which meant that there would be no profit in the early stages. Chief executive Mads Haaland-Paulsen said that figures were in line with budget and that DocMorris was slightly ahead of its plan, which is focused on establishing up to 100 pharmacies in the Swedish market.